Jackson News Reporter

Cytokine Release Syndrome Market, Size, Share, Trends, Epidemiology Forecast till 2030

 Breaking News
  • No posts were found

Cytokine Release Syndrome Market, Size, Share, Trends, Epidemiology Forecast till 2030

July 20
13:36 2020
Cytokine Release Syndrome Market, Size, Share, Trends, Epidemiology Forecast till 2030

DelveInsight Business Research LLP
DelveInsight’s “Cytokine Release Syndrome Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Cytokine Release Syndrome, historical and forecasted epidemiology as well as the Cytokine Release Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Cytokine Release Syndrome (CRS) is an acute systemic inflammatory syndrome characterized by fever and multiple organ dysfunction that is associated with chimeric antigen receptor (CAR)-T cell therapy, therapeutic antibodies, and haploidentical allogeneic transplantation.

 

Epidemiology Insights

  • Total number of patients who develop CRS in the 7MM in 2017 was 31
  • Total number of Hematologic patients receiving CART-therapies in the 7MM was 41 in 2017
  • Cytokine Release Syndrome cases in the United States in 2017 was 31
  • The population of CRS cases among the EU5 countries in 2018:-
    • Germany -13
    • France – 11
    • The United Kingdom – 11
    • Spain – 6 
    • Japan had Cytokine Release Syndrome cases in 2019 – 121
  • The patients received CAR T Cell Therapies for B-cell NHL in the United States in 2017 was 24 

Scope of Cytokine Release Syndrome market Report

  • The report covers the descriptive overview of Cytokine Release Syndrome, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Cytokine Release Syndrome epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Cytokine Release Syndrome are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Cytokine Release Syndrome market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Cytokine Release Syndrome market

Cytokine Release Syndrome Market Insight

Cytokine Release Syndrome market size in the 7MM in 2017 was USD 0.16 million

Cytokine Release Syndrome Market Drivers

  • Increasing incidence of Acute cytokine release syndrome (CRS)
  • Increasing R&D activities
  • Non-competitive landscape

Cytokine Release Syndrome Market Barriers

  • Lack of awareness about the disease
  • Lack of disease understanding
  • Misdiagnosis of CRS

 

Request for sample pages

 

 

Table of contents

1Key Insights
2 Executive Summary of Cytokine Release Syndrome
3 Cytokine Release Syndrome Market Overview at a Glance
4 Disease Background and Overview Cytokine Release Syndrome
5 Case Reports
6 Cytokine Release Syndrome Epidemiology and Patient Population
7 United States Epidemiology
8 EU5 Epidemiology
8.1 Assumptions and Rationale
8.2 Germany Epidemiology
8.3 France Epidemiology
8.4 Italy Epidemiology
8.5 Spain Epidemiology
8.6 United Kingdom Epidemiology
9 Japan Epidemiology
10 Current Cytokine Release Syndrome Treatment and Medical Practices
11 Unmet needs
12 Cytokine Release Syndrome Marketed Drugs
12.1 Actemra/RoActemra (tocilizumab): Genentech
13 Cytokine Release Syndrome Emerging Drugs
13.1 Key Cross Competition
13.2 Canakinumab (Ilaris): Novartis Pharmaceuticals
13.3 Itacitinib: Incyte Corporation
13.4 Cytosorb: CytoSorbents
13.5 Defitelio (Defibrotide): Jazz pharmaceuticals
13.6 Anakinra: Swedish Orphan Biovitrum (Sobi)
14 Cytokine Release Syndrome 7MM Market Analysis
15 Conjoint Analysis
16 United States
16.1 United States Market Outlook
16.2 United States Market Size
17 EU-5 Countries: Market Outlook
17.1 Germany Market Size
17.2 France Market Size
17.3 Italy Market Size
17.4 Spain Market Size
17.5 United Kingdom Market Size
18 Japan Market Outlook
19 Cytokine Release Syndrome Market Drivers
20 Cytokine Release Syndrome Market Barriers
21 SWOT Analysis
22 Reimbursement and market access
23 Appendix
24 DelveInsight Capabilities
25 Disclaimer
26 About DelveInsight

Media Contact
Company Name: DelveInsight
Contact Person: DelveInsight
Email: Send Email
Phone: +919650213330
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

Categories